Kim Walpole

It was suddenly like, there's a fire in me to do that and to make sure that it happens sooner than not.

Yeah, so it depends.

There are a couple of different moving parts here.

On the study design side, it takes anywhere from nine to 12 months to do that.

We're cutting that down to weeks and eventually days.

And then as you're running the clinical trial, because we are able to collect data properly, work on helping actually drive the process instead of being a system that reacts to it,

the end result, as far as we know it, can be months cut off of an actual trial.

So we're a SaaS-based, we have a SaaS-based trial model.

We charge per user, per month, per trial.

And a user can be anyone that interacts with the system at any level.

Yeah, good question.

So we're selling directly to the folks that are trying to get the treatments out.

So those are trial sponsors, Johnson and Johnson, kinds of companies, device companies, all of those different folks.

So we actually sell on a per trial basis, but then we do bundles of trials as well.

Yeah.

So on the way that clinical trials run is in order to get a treatment to market, it takes anywhere from nine to 15 years.

And there are, there's a course of trials that have to take place.

So at least three trials before you get your treatment to market.

And so,

For us, an average trial, maybe a phase two trial of 350 users would generate about 200K on average annually.